Modulight has supplied lasers and optical solutions for Iceye’s satellites.
Could I get some official documentation for that claim?
1 Like
Could you provide the actual links to the sources? This strongly appears to be an AI hallucination. You should exercise some healthy source criticism.
I don’t have anything better than that right now. It wasn’t such a serious matter, I was just pondering whether Modul might have some chance of collaborating with Iceye.
Well, I’m of a different opinion. That kind of text (edit: original message/image flagged, this comment of mine concerned a screenshot that was AI-generated text without the prompt) without an official source is very misleading. It even seems like that prompt for the AI was made with specific intent. Hopefully, this kind of activity doesn’t become common here and no one makes investment decisions based on this.
23 Likes
Modulight in good company on an export promotion trip
9 Likes
Is any progress being made? It’s very quiet and the years are rolling by. Well, summer holidays, I know, but this is frustrating.
1 Like
I see Modulight at a turning point where the investments have been made, and now it’s just down to commercial success.
The market should be positive, as data centers and quantum computers are the future. Could the quantum sector be the next megatrend?
2 Likes
The Molecular Imaging Branch (MIB) of the National Cancer Institute’s (NCI) Center for Cancer Research (CCR) at the NIH is purchasing a Modulight 8500 system for research into near-infrared photoimmunotherapy (NIR-PIT).
The value of the deal is not being disclosed at this stage, even though the bidding process is apparently formal.
"Notice of Intent: Modulight ML8500 biomedical illumination system (75N98026Q00763) In accordance with FAR Part 6.302-1, the National Institutes of Health intends to award a Firm Fixed-Price Purchase Order to Modulight USA, Inc.
The NIH, NCI, CCR, MIB (Molecular Imaging Branch) is conducting research on near-infrared photoimmunotherapy (NIR-PIT), a targeted cancer treatment that uses a monoclonal antibody linked to a light-activated dye. The MIB has been using IR700 as the photoactivatable dye for this research. More recently, the MIB identified a new dye, FI702HKT, which may provide improved performance and may be a better candidate for future patient treatment. These two dyes require different activation wavelengths: 690 nm for IR700 and 680 nm for FI702HKT. In order to compare these agents under controlled and reproducible conditions, the MIB requires a light delivery system capable of supporting both wavelengths and precise experimental control. The branch currently has other laser systems from Modulight and for continuity of research data and protocols, the MIB is requesting to purchase the ML8500 automatic illuminator system.
This notice is not a request for competitive quotes. However, any available small businesses (e.g., 8(a), service-disabled veteran owned small business, HUBZone small business, small disadvantaged business, veteran-owned small business, and women-owned small business) as stated herein may submit a written capability statement that clearly supports and demonstrates their ability to perform the requirement. A determination by the Government to compete this proposed award based upon responses to this notice is solely within the discretion of the Government.
It is anticipated that an award will be issued approximately ten (10) days after the date of this notice unless the Government determines that another vendor has the capability to meet this requirement.
Please email responses to david.shen@nih.gov no later than 11:00 p.m. EDT on July 17, 2026."
7 Likes